Frontiers | Challenges for Therapeutic Applications of Opsin-Based Optogenetic Tools in Humans
Citation numbers are available from Dimensions University of Ottawa, Canada University of Illinois at Urbana-Champaign, United States Institut National de la Santé et de la Recherche Médicale (INSERM), France Vincent Zimmern Kelly D. R. Sakaki, Kaspar Podgorski, Tristan A. Dellazizzo Toth, Patrick Coleman and Kurt Haas Kimberly L. Pietersz, Francois Du Plessis, Stephan M. Pouw, Jolanda M. Liefhebber, Sander J. van Deventer, Gerard J. M. Martens, Pavlina S. Konstantinova and Bas Blits Lina M. Tran, Andrew J. Mocle, Adam I. Ramsaran, Alexander D. Jacob, Paul W. Frankland and Sheena A. Josselyn Micah K. Madrid, Jaclyn A. Brennan, Rose T. Yin, Helen S. Knight and Igor R. Efimov Shedding Light on the Nervous System: Progress in Neurophotonics Research As the technological hurdles are overcome and optogenetic techniques advance to have more control over neurons, therapies based on these approaches will begin to emerge in the clinic. Here, we consider the technical challenges surrounding the
;import{g as i,s as o,r as s,e as a,a as u,h as l,b as c,i as h,t as f,c as d,d as p,f as m,j as g,k as y,l as b,K as v,_ as w,S as E,m as _,o as C,w as M,n as S,p as O,q as B,u as D,v as I,x as T,y as x,z as R,A as N,U as k,H as F,B as L,C as P,Y as U,D as j,E as q,F as z,G as $,I as V,J as H,L as W,M as G,N as K,O as Z,P as Y,Q as J,R as X,T as Q,V as AA,W as eA,X as tA,Z as rA,$ as nA,a0 as iA,a1 as oA,a2 as sA,a3 as aA,a4 as uA,a5 as lA,a6 as cA,a7 as hA,a8 as fA,a9 as dA,aa as pA,ab as mA,ac as gA,ad as yA,ae as bA,af as vA,ag as wA,ah as EA,ai as _A,aj as CA,ak as MA,al as SA,am as OA,an
Explore this link on the map →related reading
- Frontiers | Principles and Practice of Explainable Machine Learningfrontiersin.org
- Frontiers | A Bayesian model for chronic painfrontiersin.org
- Frontiers | Organic Molecules in Interstellar Space: Latest Advancesfrontiersin.org
- Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
- Frontiers | Why Harmless Sensations Might Hurt in Individuals with Chronic Pain: About Heightened Prediction and Perception of Pain in the Mindfrontiersin.org
- Frontiers | Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Groupfrontiersin.org
- Frontiers | Breastfeeding experiences and women's self-concept: Negotiations and dilemmas in the transition to motherhoodfrontiersin.org
- Frontiers | Antigen Cross-Presentation by Macrophagesfrontiersin.org
- Frontiers | Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportfrontiersin.org
- Frontiers | On the Cost of Knowledge: Evaluating the Boycott against Elsevierfrontiersin.org
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
- Frontiers | Simulating Emotions: An Active Inference Model of Emotional State Inference and Emotion Concept Learningfrontiersin.org